BDBM50334021 4,4-difluoro-1-(3-(4-(3-(trifluoromethyl)phenyl)-1H-imidazol-2-yl)benzyl)piperidine::CHEMBL1644683

SMILES FC(F)(F)c1cccc(c1)-c1c[nH]c(n1)-c1cccc(CN2CCC(F)(F)CC2)c1

InChI Key InChIKey=VRPKZOYEHQAUJH-UHFFFAOYSA-N

Data  2 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50334021   

TargetCannabinoid receptor 2(Human)
Merck Research Laboratory

Curated by ChEMBL
LigandPNGBDBM50334021(4,4-difluoro-1-(3-(4-(3-(trifluoromethyl)phenyl)-1...)
Affinity DataEC50:  5nMAssay Description:Agonist activity at human cloned CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2011
Entry Details Article
PubMed
TargetCannabinoid receptor 1(Human)
Merck Research Laboratory

Curated by ChEMBL
LigandPNGBDBM50334021(4,4-difluoro-1-(3-(4-(3-(trifluoromethyl)phenyl)-1...)
Affinity DataEC50:  2.55E+3nMAssay Description:Agonist activity at human cloned CB1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2011
Entry Details Article
PubMed